Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 4
1970 2
1971 3
1972 2
1974 1
1977 1
1980 1
1981 1
1983 1
1984 1
1985 3
1986 2
1987 2
1988 3
1989 8
1990 5
1991 4
1992 3
1993 5
1994 7
1995 4
1996 4
1997 5
1998 3
1999 9
2000 5
2001 8
2002 7
2003 2
2004 5
2005 11
2006 14
2007 7
2008 5
2009 8
2010 6
2011 7
2012 4
2013 6
2014 1
2015 6
2016 3
2017 1
2018 3
2019 11
2020 4
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Results by year
Filters applied: . Clear all
Page 1
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Mirza MR, Åvall Lundqvist E, Birrer MJ, dePont Christensen R, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, Ør Knudsen A, Staff S, Krog Vistisen A, Bjørge L, Mäenpää JU; AVANOVA investigators. Mirza MR, et al. Among authors: lindahl g. Lancet Oncol. 2019 Oct;20(10):1409-1419. doi: 10.1016/S1470-2045(19)30515-7. Epub 2019 Aug 29. Lancet Oncol. 2019. PMID: 31474354 Clinical Trial.
[Cervical cancer is a clinical challenge].
Bjurberg M, Beskow C, Kannisto P, Lindahl G. Bjurberg M, et al. Among authors: lindahl g. Lakartidningen. 2015 Dec 8;112:DIUS. Lakartidningen. 2015. PMID: 26646957 Free article. Review. Swedish.
Structural biology: Variability without change.
Lindahl G, Persson JJ. Lindahl G, et al. Nat Microbiol. 2016 Oct 26;1(11):16218. doi: 10.1038/nmicrobiol.2016.218. Nat Microbiol. 2016. PMID: 27782137 No abstract available.
194 results